key: cord-0854229-769q0q77
authors: Krivec, Uros; Kofol Seliger, Andreja; Tursic, Janja
title: COVID-19 lockdown dropped the rate of paediatric asthma admissions
date: 2020-05-22
journal: Arch Dis Child
DOI: 10.1136/archdischild-2020-319522
sha: 309595a3d0377937f5645d92f396c9d60d37b8f0
doc_id: 854229
cord_uid: 769q0q77

nan

Regarding common asthma attack triggers, there was a 51% to 68% decrease in admissions for acute respiratory tract infections. Airborne pollen concentrations were within seasonally expected limits. A 48% to 58% reduction in the air nitrogen dioxide (NO 2 ) level was detected, but concentrations of particulate matter with a diameter of less than 10 µm (PM 10 ) did not change substantially (table 1) . Data on admissions represent official hospital statistics. Data on pollen and air pollutants' concentrations were provided by the Institute of Public Health of the Republic of Slovenia and the Slovenian Environment Agency, respectively.

We systematically monitor paediatric asthma hospitalisation rates as a PostScript quality-of-care indicator. Longitudinal trends predict a spring admission peak. The absence of an expected increase could indicate parents' fear of attending healthcare facilities during the COVID-19 pandemic. 1 During lockdown, both hospitalised asthma cases received timely medical attention and improved after first-line treatments were administered. None was admitted to the intensive care unit.

Early reports on severe COVID-19 in people with chronic lung disease have caused considerable concern in parents of children with asthma. Guidance to regularly administer prescribed preventative drugs was provided to the public in a timely manner. Almost no routine outpatient visits occurred during the lockdown. Instead, 422 out of 491 scheduled patients with asthma were reached by phone. A large majority reported taking preventative medicines. A total of 176 drug prescriptions were issued. Viral respiratory infections are frequent triggers of asthma attacks in children. The implemented shutdown measures aimed to limit viral disease transmissions. Consequently, hospitalisations due to respiratory infections progressively dropped, reaching two instead of the expected 12 per week in lockdown week 5. Importantly, none of the hospitalised patients with asthma were SARS-CoV-2 positive.

High pollen counts and air pollutant exposure have been linked to increased asthma exacerbation and admission rates. 2 3 Over the observed period, seasonally expected levels of airborne birch and grass pollens were counted. Enforced 'stay-at-home' measures limited outdoor activities by patients. Nevertheless, both hospitalised patients were allergic to grass pollen.

Substantial air quality improvement during the lockdown has been reported. 4 Similarly, we observed a significant decrease in urban background NO 2 levels. Of note, 3 days of extremely high daily PM 10 values were detected due to a large desert dust outbreak. This event did not significantly alter the cumulative daily mean PM 10 concentration nor did it affect asthma admission events after a lag period.

Citizens' adherence to strict lockdown measures effectively limited COVID-19 spread throughout the community and saved many human lives. Moreover, these unprecedented social circumstances also dropped the occurrence of common childhood illnesses that require hospital care, such as asthma.

Uros Krivec, 1 Andreja Kofol Seliger, 2 Janja Tursic 3

Delayed access or provision of care in Italy resulting from fear of COVID-19

Fine particulate pollution and asthma exacerbations

Pollen exposure and hospitalization due to asthma exacerbations: daily time series in a european city

Changes in air quality during the lockdown in Barcelona (spain) one month into the sArs-CoV-2 epidemic

Patient consent for publication Not required.Provenance and peer review Not commissioned; internally peer reviewed. this article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.